After 10 weeks of mammary fat pad injection, 1 × 103 and 1 × 102 ICAM2-overexpressing groups exhibited 100% and 50% of tumor-initiation ability, respectively, compared with control groups, which already had 50% and 0% tumor-initiation ability (Fig. 4D). This evidence concerns the gene ICAM2 and neoplasm.